Thyroid Dysfunction in Adult Long-term Survivors After Hemapoeitic Stem-cell Transplantation (HSCT)

Abstract

Thyroid function was evaluated in 72 adult survivors (41 females and 31 males) at 16 to 56 years of age, 1.5 years mean time (range 0.2 - 9.8) after hemapoeitic stem cell transplantation (HSCT) with no known prior history of thyroid dysfunction. Thyroid stimulating hormone (TSH) and free thyroxin levels (FT₄) were determined before and after stimulation with thyrotropin releasing hormone (TRH). Conditioning regimens for HSCT did not include TBI. Overt hypothyroidism (basal TSH > 8 μIU/ml, FT₄ < 0.8 ng/dl) was observed in 6 % of male patients and 5 % of female patients; subclinical hypothyroidism (basal TSH 4 - 8 μIU/ml, low normal FT₄ 0.8 - 1.9 ng/dl) was observed in 13 % of males and 5 % of females. A significant number of euthyroid patients (40 % males and 54 % females) with normal basal TSH and FT₄ levels overresponded to TRH stimulation; the finding being statistically significant (p < 0.005). A heavy TSH response after TRH stimulation indicates compensated subclinical dysfunction of the thyroid gland. Chemotherapy-only conditioning regimens may have an adverse effect on thyroid gland function not always detected by determination of basal TSH and FT₄ levels. This finding warrants long-term evaluation of thyroid function in HSCT patients.

Thyroid dysfunction - Overt primary hypothyroidism - Subclinical hypothyroidism

References

• 1 Kauppila M, Koskinen P, Irjala K, Remes K, Viikari J. Long-term effects of allogenic bone marrow transplantation (BMT) on pituitary, gonad, thyroid and adrenal function in adults.  Bone Marrow Transpl. 1998;  22 331-337
• 2 Tauchmanova L, Selleri C, de Rosa G, Pagano L, Orio F, Lombardi G, Rotoli B, Colao A. High prevalence of endocrine dysfunction in long-term survivors after allogenic bone marrow transplantation for hematological diseases.  Cancer. 2002;  95 1076-1084
• 3 Kolb H J, Bender-Gotze C. Late complications after allogenic bone marrow transplantation for leukaemia.  Bone Marrow Transpl. 1990;  6 61-72
• 4 Larsen P R, Davies T F, Hay I D. The Thyroid Gland. In: Jean D, Wilson JD Foster DW, Kronenberg HM, Larsen PR (eds) Williams Textbook of Endocrinology, 9^th edition. Philadelphia; W. B. Saunders company 1998: 389-517
• 5 Refetoff S. Thyroid function tests and effects of drugs on thyroid function. In: De Groot LJ (ed) Endocrinology. Philadelphia; W. B. Saunders company 1989: 590-640
• 6 Dufour D R, Gaskin J H, Jubiz W A. Dynamic Procedures in Endocrinology. In: Becker KL (ed) Principles and Practice of Endocrinology and Metabolism. Philadelphia; J. B. Lipincott Company 1990: 1766-1775
• 7 Al-Fiar F Z, Colwill R, Lipton J H, Fyles G, Spaner D, Messner H. Abnormal thyroid stimulating hormone (TSH) levels in adults following allogenic bone marrow transplants.  Bone Marrow Transpl. 1997;  19 1019-1022
• 8 Katsanis E, Shapiro R S, Robison L L, Haake R J, Kim T, Pescovitz O H, Ramsay N KC. Thyroid dysfunction following bone marrow transplantation: long-term follow-up of 80 pediatric patients.  Bone Marrow Transpl. 1990;  5 335-340
• 9 Cohen A, Rovelli R, Zecca S, VanLint M T, Parodi L, Grasso L, Uredzo C. Endocrine late effects in children who underwent bone marrow transplantation: review.  Bone Marrow Transpl. 1998;  21 (Suppl 2) 564-567
• 10 Lee W Y, Oh E S, Min C K, Kim D W, Lee J W, Kang M I, Min W S, Cha B Y, Lee K W, Son H Y, Kang S K, Kimm C C. Post transplant complications. Changes in autoimmune thyroid disease following allogenic bone marrow transplantation.  Bone Marrow Transpl. 2001;  28 63-66
• 11 Brennan B, Shalet S M. Endocrine late effects after bone marrow transplant.  Br J Haematol. 2002;  118 58-66
• 12 Utiger R D. Hypothyroidism. In: De Groot LJ (ed) Endocrinology Philadelphia; W. B. Saunders company 1989: 702-722